Irritable bowel syndrome differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 50: Line 50:
! style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice  
! style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice  
! style="background:#4479BA; color: #FFFFFF;" align="center" |Diarrhea
! style="background:#4479BA; color: #FFFFFF;" align="center" |Diarrhea
! style="background:#4479BA; color: #FFFFFF;" align="center" |GI Bleed
! style="background:#4479BA; color: #FFFFFF;" align="center" |Melena/ hematochezia/ hemtemesis
! style="background:#4479BA; color: #FFFFFF;" align="center" |Hypo-
! style="background:#4479BA; color: #FFFFFF;" align="center" |Hypo-
tension
tension
Line 802: Line 802:
|}
|}


=== '''Differential Diagnosis of Irritable bowel syndrome on the basis of diarrhea:''' ===
=== '''Differential Diagnosis of Irritable bowel syndrome on the basis of abdominal pain and diarrhea:''' ===
[[Diarrhea]] may be caused by [[infectious diseases]], [[celiac disease]],<ref>{{cite journal |author=Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS |title=Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis |journal=Gastroenterology |volume=126 |issue=7 |pages=1721-32 |year=2004 |pmid=15188167 |doi=}}</ref> [[parasites]],<ref>{{cite journal |author=Stark D, van Hal S, Marriott D, Ellis J, Harkness J. |title=Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. |journal=Int J Parasitol. |volume= 31 |issue=1 |pages=11-20|year=2007 |pmid=17070814 |doi=}}</ref> [[food allergies]]<ref>{{cite journal |author=Drisko ''et al'' |title=Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics |journal=Journal of the American College of Nutrition |volume=25 |issue=6 |pages=514-22 |year=2006 |pmid=17229899 |doi=}}</ref> and [[lactose intolerance]].<ref>{{cite journal |author=Vernia P, Ricciardi MR, Frandina C, Bilotta T, Frieri G |title=Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet |journal=The Italian journal of gastroenterology |volume=27 |issue=3 |pages=117-21 |year=1995 |pmid=7548919 |doi=}}</ref>  See the [[list of causes of diarrhea]] for other conditions which can cause diarrhea. [[Coeliac disease|Celiac disease]] in particular is most often misdiagnosed as IBS.<ref>http://digestive.niddk.nih.gov/ddiseases/pubs/celiac/ - The United States National Institutes of Health Celiac Disease Page</ref>
[[Diarrhea]] with [[abdominal pain]]/cramping may be caused by [[infectious diseases]], [[celiac disease]],<ref>{{cite journal |author=Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS |title=Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis |journal=Gastroenterology |volume=126 |issue=7 |pages=1721-32 |year=2004 |pmid=15188167 |doi=}}</ref> [[parasites]],<ref>{{cite journal |author=Stark D, van Hal S, Marriott D, Ellis J, Harkness J. |title=Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. |journal=Int J Parasitol. |volume= 31 |issue=1 |pages=11-20|year=2007 |pmid=17070814 |doi=}}</ref> [[food allergies]]<ref>{{cite journal |author=Drisko ''et al'' |title=Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics |journal=Journal of the American College of Nutrition |volume=25 |issue=6 |pages=514-22 |year=2006 |pmid=17229899 |doi=}}</ref> and [[lactose intolerance]].<ref>{{cite journal |author=Vernia P, Ricciardi MR, Frandina C, Bilotta T, Frieri G |title=Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet |journal=The Italian journal of gastroenterology |volume=27 |issue=3 |pages=117-21 |year=1995 |pmid=7548919 |doi=}}</ref>  See the [[list of causes of diarrhea]] for other conditions which can cause [[diarrhea]]. [[Coeliac disease|Celiac disease]] in particular is most often misdiagnosed as IBS.<ref>http://digestive.niddk.nih.gov/ddiseases/pubs/celiac/ - The United States National Institutes of Health Celiac Disease Page</ref>
The differential diagnosis of Irritable Bowel Syndrome based on diarrhea is as follows:<ref name="pmid26913568">{{cite journal |vauthors=Guagnozzi D, Arias Á, Lucendo AJ |title=Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders |journal=Aliment. Pharmacol. Ther. |volume=43 |issue=8 |pages=851–862 |year=2016 |pmid=26913568 |doi=10.1111/apt.13573 |url=}}</ref><ref name="pmid27796144">{{cite journal |vauthors=Hilpüsch F, Johnsen PH, Goll R, Valle PC, Sørbye SW, Abelsen B |title=Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome |journal=Scand. J. Gastroenterol. |volume=52 |issue=2 |pages=173–177 |year=2017 |pmid=27796144 |doi=10.1080/00365521.2016.1242025 |url=}}</ref><ref name="pmid14201408">{{cite journal| author=SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA| title=EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME. | journal=Gastroenterology | year= 1964 | volume= 47 | issue=  | pages= 184-7 | pmid=14201408 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14201408  }} </ref><ref name="pmid15188167">{{cite journal |vauthors=Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS |title=Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis |journal=Gastroenterology |volume=126 |issue=7 |pages=1721–32 |year=2004 |pmid=15188167 |doi= |url=}}</ref><ref name="pmid27753436">{{cite journal |vauthors=Irvine AJ, Chey WD, Ford AC |title=Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis |journal=Am. J. Gastroenterol. |volume=112 |issue=1 |pages=65–76 |year=2017 |pmid=27753436 |doi=10.1038/ajg.2016.466 |url=}}</ref><ref name="pmid20634346">{{cite journal |vauthors=van Rheenen PF, Van de Vijver E, Fidler V |title=Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis |journal=BMJ |volume=341 |issue= |pages=c3369 |year=2010 |pmid=20634346 |pmc=2904879 |doi= |url=}}</ref><ref name="pmid25913530">{{cite journal |vauthors=Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD |title=Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea |journal=Aliment. Pharmacol. Ther. |volume=42 |issue=1 |pages=3–11 |year=2015 |pmid=25913530 |doi=10.1111/apt.13227 |url=}}</ref><ref name="pmid25238408">{{cite journal |vauthors=Canavan C, Card T, West J |title=The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study |journal=PLoS ONE |volume=9 |issue=9 |pages=e106478 |year=2014 |pmid=25238408 |pmc=4169512 |doi=10.1371/journal.pone.0106478 |url=}}</ref><ref name="pmid19364994">{{cite journal |vauthors=Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P |title=Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis |journal=Arch. Intern. Med. |volume=169 |issue=7 |pages=651–8 |year=2009 |pmid=19364994 |doi=10.1001/archinternmed.2009.22 |url=}}</ref><ref name="pmid19602448">{{cite journal |vauthors=Ford AC, Spiegel BM, Talley NJ, Moayyedi P |title=Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis |journal=Clin. Gastroenterol. Hepatol. |volume=7 |issue=12 |pages=1279–86 |year=2009 |pmid=19602448 |doi=10.1016/j.cgh.2009.06.031 |url=}}</ref>
The differential diagnosis of irritable bowel syndrome based on abdominal pain and [[diarrhea]] is as follows:<ref name="pmid26913568">{{cite journal |vauthors=Guagnozzi D, Arias Á, Lucendo AJ |title=Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders |journal=Aliment. Pharmacol. Ther. |volume=43 |issue=8 |pages=851–862 |year=2016 |pmid=26913568 |doi=10.1111/apt.13573 |url=}}</ref><ref name="pmid27796144">{{cite journal |vauthors=Hilpüsch F, Johnsen PH, Goll R, Valle PC, Sørbye SW, Abelsen B |title=Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome |journal=Scand. J. Gastroenterol. |volume=52 |issue=2 |pages=173–177 |year=2017 |pmid=27796144 |doi=10.1080/00365521.2016.1242025 |url=}}</ref><ref name="pmid14201408">{{cite journal| author=SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA| title=EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME. | journal=Gastroenterology | year= 1964 | volume= 47 | issue=  | pages= 184-7 | pmid=14201408 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14201408  }} </ref><ref name="pmid15188167">{{cite journal |vauthors=Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS |title=Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis |journal=Gastroenterology |volume=126 |issue=7 |pages=1721–32 |year=2004 |pmid=15188167 |doi= |url=}}</ref><ref name="pmid27753436">{{cite journal |vauthors=Irvine AJ, Chey WD, Ford AC |title=Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis |journal=Am. J. Gastroenterol. |volume=112 |issue=1 |pages=65–76 |year=2017 |pmid=27753436 |doi=10.1038/ajg.2016.466 |url=}}</ref><ref name="pmid20634346">{{cite journal |vauthors=van Rheenen PF, Van de Vijver E, Fidler V |title=Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis |journal=BMJ |volume=341 |issue= |pages=c3369 |year=2010 |pmid=20634346 |pmc=2904879 |doi= |url=}}</ref><ref name="pmid25913530">{{cite journal |vauthors=Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD |title=Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea |journal=Aliment. Pharmacol. Ther. |volume=42 |issue=1 |pages=3–11 |year=2015 |pmid=25913530 |doi=10.1111/apt.13227 |url=}}</ref><ref name="pmid25238408">{{cite journal |vauthors=Canavan C, Card T, West J |title=The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study |journal=PLoS ONE |volume=9 |issue=9 |pages=e106478 |year=2014 |pmid=25238408 |pmc=4169512 |doi=10.1371/journal.pone.0106478 |url=}}</ref><ref name="pmid19364994">{{cite journal |vauthors=Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P |title=Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis |journal=Arch. Intern. Med. |volume=169 |issue=7 |pages=651–8 |year=2009 |pmid=19364994 |doi=10.1001/archinternmed.2009.22 |url=}}</ref><ref name="pmid19602448">{{cite journal |vauthors=Ford AC, Spiegel BM, Talley NJ, Moayyedi P |title=Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis |journal=Clin. Gastroenterol. Hepatol. |volume=7 |issue=12 |pages=1279–86 |year=2009 |pmid=19602448 |doi=10.1016/j.cgh.2009.06.031 |url=}}</ref>
 
 
The diffrentials of chronic watery [[diarrhea]] are as follows:
{| class="wikitable"
{| class="wikitable"
! colspan="3" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Cause
! colspan="3" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Cause
Line 843: Line 840:
|
|
* [[Abdominal pain]] and [[diarrhea]]
* [[Abdominal pain]] and [[diarrhea]]
* Dyspepsia
* [[Dyspepsia]]
* Upper or lower GI bleeding
* Upper or lower [[gastrointestinal bleeding]]
|
|
* [[Abdominal]][[Tenderness|tenderness when]]<nowiki/>palpated in severe [[disease]]
* [[Abdominal]][[Tenderness|tenderness when]]<nowiki/>palpated in severe [[disease]]
Line 862: Line 859:
|
|
* [[Abdominal pain]] and [[diarrhea]]
* [[Abdominal pain]] and [[diarrhea]]
* Dyspepsia
* [[Dyspepsia]]
* Upper or lower GI bleeding
* Upper or lower [[gastrointestinal bleeding]]
|
|
* Lump in the neck
* Lump in the neck
Line 922: Line 919:
| +
| +
|
|
* May be asymptomatic
* May be [[asymptomatic]]
* Vague [[abdominal pain]]
* Vague [[abdominal pain]]
* [[Diarrhea]]
* [[Diarrhea]]
* [[Weight loss]]
* [[Weight loss]]
* [[Malabsorption]]/ [[steatorrhea]]
* [[Malabsorption]]/ [[steatorrhea]]
* Bloatedness
* [[Bloating]]
|
|
** [[Abdominal pain]] and [[cramping]]
** [[Abdominal pain]] and [[cramping]]
Line 934: Line 931:
** [[Mouth ulcers]]
** [[Mouth ulcers]]
** [[Dermatitis herpetiformis]]
** [[Dermatitis herpetiformis]]
** Signs of the fat-soluble [[Vitamin A|vitamins A]], D, E, and K deficiency
** Signs of the fat-soluble [[Vitamin A|vitamins A]], [[Vitamin D|D]], [[Vitamin E|E]], and [[Vitamin K|K]] deficiency
|
|
* [[IgA]] tissue [[transglutaminase]]Ab
* [[IgA]] tissue [[transglutaminase]] [[antibody]]
|
|
* [[Gluten-free diet]]
* [[Gluten-free diet]]
Line 949: Line 946:
* Onset associated with change in frequency of [[stool]]
* Onset associated with change in frequency of [[stool]]


* Onset associated with change in consistency or form of stool
* Onset associated with change in consistency or form of [[stool]]
 
* Straining during [[defecation]], [[dyspepsia]], [[bloating]] and [[flatulence]] may be present
Straining during defecation, dyspepsia, bloating and flatulence may be present
|
|
* [[Abdominal tenderness]]
* [[Abdominal tenderness]]
* Hard stool in the rectal vault
* Hard [[stool]] in the [[rectal]] vault
|[[Diagnosis|Clinical diagnosis]]
|[[Diagnosis|Clinical diagnosis]]
* ROME IV criteria
* ROME IV criteria
* Exclusion of organcic causes based on Laboratory Investigations and Imaging
* Exclusion of organic causes based on laboratory investigations and imaging
|
|
* Low FODMAP diet, high [[dietary fiber]], physical exercise
* Low FODMAP diet ([[fructose]] -when in excess of [[glucose]], [[fructans]], galacto-[[oligosaccharides]], [[lactose]] and [[polyols]] (eg. [[sorbitol]] and [[mannitol]]), high [[dietary fiber]], physical exercise
* [[Osmotic]] [[laxatives]] such as [[polyethylene glycol]], [[sorbitol]], and [[lactulose]] for constipation predominant IBS
* [[Osmotic]] [[laxatives]] such as [[polyethylene glycol]], [[sorbitol]], and [[lactulose]] for [[constipation]] predominant IBS
*Opioids such as Loperamide and chloride channel activators such as Linactolide and Lubipristone for diarrhea predominant IBS
*[[Opioids]] such as [[loperamide]] and chloride channel activators such as linactolide and lubipristone for diarrhea predominant IBS
* [[Antispasmodic]]<nowiki/>drugs (e.g. [[Anticholinergic|anticholinergics]]<nowiki/> such as [[hyoscyamine]]<nowiki/> or [[dicyclomine]]), antidepressants and anxiolytics for pain predominant IBS
* [[Antispasmodic]]<nowiki/>drugs (e.g. [[Anticholinergic|anticholinergics]]<nowiki/> such as [[hyoscyamine]]<nowiki/> or [[dicyclomine]]), [[antidepressants]] and [[anxiolytics]] for pain predominant IBS
|}
|}


{{WikiDoc Help Menu}} {{WikiDoc Sources}}
=== Differential diagnosis based on diarrhea ===
 
The following table outlines the major differential diagnoses based on [[diarrhea]] as the major presenting [[symptom]]:
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center"
| valign="top" |
| valign="top" |
Line 976: Line 972:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Crohn's disease]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Crohn's disease]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Diarrhea]], abdominal pain
* [[Diarrhea]], [[abdominal pain]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Colonoscopy]], [[small bowel barium radiograph]], [[CT enterography]], [[magnetic resonance enterography]]
* [[Colonoscopy]], [[small bowel barium radiograph]], [[CT enterography]], [[magnetic resonance enterography]]
Line 988: Line 984:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Microscopic colitis]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Microscopic colitis]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Watery diarrhea]] with nocturnal symptoms
* [[Watery diarrhea]] with nocturnal [[Symptom|symptoms]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Colonoscopy]], [[flexible sigmoidoscopy]] and biopsy
* [[Colonoscopy]], [[flexible sigmoidoscopy]] and [[biopsy]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Celiac disease]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Celiac disease]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Diarrhea, [[steatorrhea]], anemia
* [[Diarrhea]], [[steatorrhea]], [[anemia]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Endoscopy with small bowel biopsy, [[Tissue transglutaminase antibody]]
* [[Endoscopy]] with [[small bowel]] biopsy, [[tissue transglutaminase]] [[antibody]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Neuroendocrine tumor]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Neuroendocrine tumor]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Gastrinoma]], [[Carcinoid]] and [[VIP producing tumor]]
* [[Gastrinoma]], [[carcinoid]] and [[VIPoma|VIP producing tumor]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Urine 5HIAA]], fasting gastritis(followed by [[secretin]] stimulation test), [[serum VIP]]
* [[Urine 5HIAA]], fasting [[gastrin]] levels (followed by [[secretin]] stimulation test), [[serum]] [[VIP]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Hyperthyroidism]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Hyperthyroidism]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Increased appetite, insomnia, [[diarrhea]], [[palpitations]], heat intolerance, increased sweating
* Increased [[appetite]], [[insomnia]], [[diarrhea]], [[palpitations]], heat intolerance, increased [[sweating]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Serum [[TSH]] levels
* Serum [[TSH]] levels
Line 1,012: Line 1,008:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Lactose intolerance]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Lactose intolerance]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Flatulence]], bloating with lactose consumption
*[[Flatulence]], [[bloating]] with [[lactose]] consumption
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Avoidance trial, [[lactose breath test]]
* Avoidance trial, lactose breath test
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Infectious]] causes
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Infectious]] causes
Line 1,026: Line 1,022:
* [[Bloating]], [[diarrhea]], [[abdominal distension]]
* [[Bloating]], [[diarrhea]], [[abdominal distension]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Jejunal aspirate]], [[lactulose breath hydrogen test]], [[antibiotic trial]]
* [[Jejunum|Jejunal]] aspirate, [[lactulose]] breath hydrogen test, [[antibiotic]] trial
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Clostridium difficile]] [[infection]]([[Psuedomembranous colitis]])
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Clostridium difficile]] [[infection]]([[Pseudomembranous enterocolitis|Psuedomembranous colitis]])
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Recent [[antibiotic]] [[treatment]]
* Recent [[antibiotic]] [[treatment]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Stool [[Polymerase Chain reaction]]
* [[Stool]] [[polymerase chain reaction]]
|}
|}


===Differential Diagnosis of Irritable Bowel Syndrome on the basis of Constipation:===
===Differential diagnosis of irritable bowel syndrome on the basis of constipation:===
The differential diagnosis of Irritable bowel Syndrome based on constipation is as follows:<ref name="pmid16678566">{{cite journal |vauthors=Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS |title=Childhood functional gastrointestinal disorders: child/adolescent |journal=Gastroenterology |volume=130 |issue=5 |pages=1527–37 |year=2006 |pmid=16678566 |doi=10.1053/j.gastro.2005.08.063 |url=}}</ref><ref name="pmid12425553">{{cite journal |vauthors=Cash BD, Schoenfeld P, Chey WD |title=The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review |journal=Am. J. Gastroenterol. |volume=97 |issue=11 |pages=2812–9 |year=2002 |pmid=12425553 |doi=10.1111/j.1572-0241.2002.07027.x |url=}}</ref><ref name="pmid10235207">{{cite journal |vauthors=Hamm LR, Sorrells SC, Harding JP, Northcutt AR, Heath AT, Kapke GF, Hunt CM, Mangel AW |title=Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria |journal=Am. J. Gastroenterol. |volume=94 |issue=5 |pages=1279–82 |year=1999 |pmid=10235207 |doi=10.1111/j.1572-0241.1999.01077.x |url=}}</ref><ref name="pmid20456760">{{cite journal |vauthors=Prott G, Shim L, Hansen R, Kellow J, Malcolm A |title=Relationships between pelvic floor symptoms and function in irritable bowel syndrome |journal=Neurogastroenterol. Motil. |volume=22 |issue=7 |pages=764–9 |year=2010 |pmid=20456760 |doi=10.1111/j.1365-2982.2010.01503.x |url=}}</ref><ref name="pmid8995945">{{cite journal |vauthors=Voderholzer WA, Schatke W, Mühldorfer BE, Klauser AG, Birkner B, Müller-Lissner SA |title=Clinical response to dietary fiber treatment of chronic constipation |journal=Am. J. Gastroenterol. |volume=92 |issue=1 |pages=95–8 |year=1997 |pmid=8995945 |doi= |url=}}</ref><ref name="pmid20152787">{{cite journal |vauthors=Spiller R, Camilleri M, Longstreth GF |title=Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? |journal=Clin. Gastroenterol. Hepatol. |volume=8 |issue=2 |pages=125–9; discussion 129–36 |year=2010 |pmid=20152787 |doi=10.1016/j.cgh.2009.12.018 |url=}}</ref><ref name="pmid20179692">{{cite journal |vauthors=Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K |title=Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial |journal=Am. J. Gastroenterol. |volume=105 |issue=4 |pages=890–6 |year=2010 |pmid=20179692 |pmc=3910270 |doi=10.1038/ajg.2010.53 |url=}}</ref><ref name="pmid20179696">{{cite journal |vauthors=Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD |title=The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial |journal=Am. J. Gastroenterol. |volume=105 |issue=4 |pages=859–65 |year=2010 |pmid=20179696 |pmc=2887227 |doi=10.1038/ajg.2010.55 |url=}}</ref><ref name="pmid23357491">{{cite journal |vauthors=Begtrup LM, Engsbro AL, Kjeldsen J, Larsen PV, Schaffalitzky de Muckadell O, Bytzer P, Jarbøl DE |title=A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome |journal=Clin. Gastroenterol. Hepatol. |volume=11 |issue=8 |pages=956–62.e1 |year=2013 |pmid=23357491 |doi=10.1016/j.cgh.2012.12.038 |url=}}</ref><ref name="pmid23826010">{{cite journal |vauthors=Mehdi Z, Sakineh E, Mohammad F, Mansour R, Alireza A |title=Celiac disease: Serologic prevalence in patients with irritable bowel syndrome |journal=J Res Med Sci |volume=17 |issue=9 |pages=839–42 |year=2012 |pmid=23826010 |pmc=3697208 |doi= |url=}}</ref>
The differential diagnosis of irritable bowel syndrome based on [[constipation]] as the predominant [[symptom]] is as follows:<ref name="pmid16678566">{{cite journal |vauthors=Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS |title=Childhood functional gastrointestinal disorders: child/adolescent |journal=Gastroenterology |volume=130 |issue=5 |pages=1527–37 |year=2006 |pmid=16678566 |doi=10.1053/j.gastro.2005.08.063 |url=}}</ref><ref name="pmid12425553">{{cite journal |vauthors=Cash BD, Schoenfeld P, Chey WD |title=The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review |journal=Am. J. Gastroenterol. |volume=97 |issue=11 |pages=2812–9 |year=2002 |pmid=12425553 |doi=10.1111/j.1572-0241.2002.07027.x |url=}}</ref><ref name="pmid10235207">{{cite journal |vauthors=Hamm LR, Sorrells SC, Harding JP, Northcutt AR, Heath AT, Kapke GF, Hunt CM, Mangel AW |title=Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria |journal=Am. J. Gastroenterol. |volume=94 |issue=5 |pages=1279–82 |year=1999 |pmid=10235207 |doi=10.1111/j.1572-0241.1999.01077.x |url=}}</ref><ref name="pmid20456760">{{cite journal |vauthors=Prott G, Shim L, Hansen R, Kellow J, Malcolm A |title=Relationships between pelvic floor symptoms and function in irritable bowel syndrome |journal=Neurogastroenterol. Motil. |volume=22 |issue=7 |pages=764–9 |year=2010 |pmid=20456760 |doi=10.1111/j.1365-2982.2010.01503.x |url=}}</ref><ref name="pmid8995945">{{cite journal |vauthors=Voderholzer WA, Schatke W, Mühldorfer BE, Klauser AG, Birkner B, Müller-Lissner SA |title=Clinical response to dietary fiber treatment of chronic constipation |journal=Am. J. Gastroenterol. |volume=92 |issue=1 |pages=95–8 |year=1997 |pmid=8995945 |doi= |url=}}</ref><ref name="pmid20152787">{{cite journal |vauthors=Spiller R, Camilleri M, Longstreth GF |title=Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? |journal=Clin. Gastroenterol. Hepatol. |volume=8 |issue=2 |pages=125–9; discussion 129–36 |year=2010 |pmid=20152787 |doi=10.1016/j.cgh.2009.12.018 |url=}}</ref><ref name="pmid20179692">{{cite journal |vauthors=Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K |title=Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial |journal=Am. J. Gastroenterol. |volume=105 |issue=4 |pages=890–6 |year=2010 |pmid=20179692 |pmc=3910270 |doi=10.1038/ajg.2010.53 |url=}}</ref><ref name="pmid20179696">{{cite journal |vauthors=Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD |title=The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial |journal=Am. J. Gastroenterol. |volume=105 |issue=4 |pages=859–65 |year=2010 |pmid=20179696 |pmc=2887227 |doi=10.1038/ajg.2010.55 |url=}}</ref><ref name="pmid23357491">{{cite journal |vauthors=Begtrup LM, Engsbro AL, Kjeldsen J, Larsen PV, Schaffalitzky de Muckadell O, Bytzer P, Jarbøl DE |title=A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome |journal=Clin. Gastroenterol. Hepatol. |volume=11 |issue=8 |pages=956–62.e1 |year=2013 |pmid=23357491 |doi=10.1016/j.cgh.2012.12.038 |url=}}</ref><ref name="pmid23826010">{{cite journal |vauthors=Mehdi Z, Sakineh E, Mohammad F, Mansour R, Alireza A |title=Celiac disease: Serologic prevalence in patients with irritable bowel syndrome |journal=J Res Med Sci |volume=17 |issue=9 |pages=839–42 |year=2012 |pmid=23826010 |pmc=3697208 |doi= |url=}}</ref>
{|
{|
|-
|-
Line 1,056: Line 1,052:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Hypothyroidism]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Hypothyroidism]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Fatigue, increased sensitivity to cold, dry skin, [[constipation]], weight gain, puffy face, muscle weakness, [[hoarseness]]
* [[Fatigue]], increased sensitivity to cold, [[dry skin]], [[constipation]], [[weight gain]], puffy face, [[muscle weakness]], [[hoarseness]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Serum [[Thyroid Stimulating Hormone]] levels
* [[Serum]] [[Thyroid-stimulating hormone|thyroid stimulating hormone]] levels
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Medication
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Medication
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Opiates]], [[cholestyramine]], [[Calcium-channel blockers]], [[Anticholinergic medications]]
* [[Opiates]], [[cholestyramine]], [[calcium-channel blockers]], [[anticholinergic]] medications
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Medication history.
* Medication history.
Line 1,068: Line 1,064:
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Neurologic disease
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Neurologic disease
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Concurrent [[multiple sclerosis]], [[Parkinson disease]], autonomic dysfunction(Shy-Drager)
* Concurrent [[multiple sclerosis]], [[Parkinson disease]], autonomic dysfunction ([[Shy-Drager syndrome|Shy-Drager]])
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* History and neurologic examination
* History and [[Neurological|neurologic]] examination
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Pelvic floor dysfunction
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Pelvic floor dysfunction
Line 1,076: Line 1,072:
* Straining, self digitation
* Straining, self digitation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Rectal examination, [[defecography]], [[anorectal manometry]], [[balloon expulsion study]]
* [[Rectal examination]], defecography, anorectal manometry, [[balloon expulsion study]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Colonic inertia]]
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |[[Colonic inertia]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Infrequent [[bowel movements]]
* Infrequent [[Bowel movement|bowel movements]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Radiopaque markers]], [[scintigraphy]], wireless pH and motility capsule
* [[Radiopaque markers]], [[scintigraphy]], wireless pH and motility capsule

Revision as of 17:52, 2 December 2017

Irritable bowel syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Irritable bowel syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Monitoring

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Irritable bowel syndrome differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Irritable bowel syndrome differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Irritable bowel syndrome differential diagnosis

CDC on Irritable bowel syndrome differential diagnosis

Irritable bowel syndrome differential diagnosis in the news

Blogs on Irritable bowel syndrome differential diagnosis

Directions to Hospitals Treating Irritable bowel syndrome

Risk calculators and risk factors for Irritable bowel syndrome differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]

Overview

Irritable bowel syndrome must be differentiated from other diseases that cause diarrhea, constipation, and abdominal pain, such as Celiac disease, Inflammatory bowel disease(Crohn's disease and Ulcerative colitis) Thyroid disease (Hyper or Hypothyroidism), strictures due to ischemia, diverticulitis or ischemia, among others.

The differential diagnosis for Irritable bowel syndrome can be listed based on predominant symptoms, such as constipation predominant, diarrhea predominant and pain predominant diseases.

Differentiating Irritable Bowel Syndrome from other Diseases

Diseases with similar symptoms

Differential diagnosis of abdominal pain

The differential diagnosis of IBS based on abdominal pain is as follows:

Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin

Classification of pain in the abdomen based on etiology Disease Clinical manifestations Diagnosis Comments
Symptoms Signs
Fever Rigors and chills Abdominal Pain Jaundice Diarrhea Melena/ hematochezia/ hemtemesis Hypo-

tension

Guarding Rebound Tenderness Bowel sounds Lab Findings Imaging
Abdominal causes Inflammatory causes Pancreato-biliary disorders Acute suppurative cholangitis + + RUQ + + + + N
  • Abnormal LFT
  • WBC >10,000
Ultrasound shows biliary dilatation/stents/tumor Septic shock occurs with features of SIRS
Acute cholangitis + RUQ + N Ultrasound shows biliary dilatation/stents/tumor Biliary drainage (ERCP) + IV antibiotics
Acute cholecystitis + RUQ + Hypoactive Ultrasound shows gallstone and evidence of inflammation Murphy’s sign
Acute pancreatitis + Epigastric ± ± N Ultrasound shows evidence of inflammation Pain radiation to back
Primary biliary cirrhosis RUQ/Epigastric + N
  • Increased AMA level, abnormal LFTs
Primary sclerosing cholangitis + RUQ + N ERCP and MRCP shows
  • Multiple segmental strictures
  • Mural irregularities
  • Biliary dilatation and diverticula
  • Distortion of biliary tree
The risk of cholangiocarcinoma in patients with primary sclerosing cholangitis is 400 times higher than the risk in the general population.
Cholelithiasis ± RUQ/Epigastric ± + + N to hyperactive for dislodged stone Ultrasound shows gallstone Murphy’s sign
Gastric causes Peptic ulcer disease ± Diffuse + in perforated + + N
  • Ascitic fluid
    • LDH > serum LDH
    • Glucose < 50mg/dl
    • Total protein > 1g/dl
Air under diaphragm in upright CXR Upper GI endoscopy for diagnosis
Gastritis ± Epigastric + in chronic gastritis
Gastroesophageal reflux disease Epigastric
Gastric outlet obstruction Epigastric ± Hyperactive
Gastrointestinal perforation + ± Diffuse ± +, depends on site + + ±
  • WBC> 10,000
Air under diaphragm in upright CXR
Dumping syndrome Lower and then diffuse
Intestinal causes Acute appendicitis + +in pyogenic appendicitis Starts in epigastrium, migrates to RLQ + in perforated appendicitis + + Hypoactive Ultrasound shows evidence of inflammation Nausea & vomiting, decreased appetite
Acute diverticulitis + ± LLQ Hematochezia + Hypoactive CT scan and ultrasound shows evidence of inflammation
Inflammatory bowel disease ± Diffuse ± Hematochezia
Irritable bowel syndrome ± Diffuse + N Tests done to exclude other diseases as it diagnosis of exclusion Tests done to exclude other diseases as it diagnosis of exclusion Symptomatic treatment
Whipple's disease ± Diffuse ± ± N *Endoscopy is used to confirm diagnosis.

Images used to find complications

Extra intestinal findings:
Toxic megacolon + Diffuse + + ± Hypoactive CT scan shows:

Ultrasound shows:

  • Loss of haustra coli of the colon
  • Hypoechoic and thickened bowel walls with irregular internal margins in the sigmoid and descending colon
  • Prominent dilation of the transverse colon (>6 cm)
  • Insignificant dilation of ileal bowel loops (diameter >18 mm) with increased intraluminal gas and fluid
Tropical sprue + Diffuse +
Celiac disease Diffuse ±, also dermatitis herpetiformis + Hyperactive (increased sounds)
Infective colitis +
Hepatic causes Viral hepatitis + RUQ + +
Liver masses + + in Liver abscess RUQ ± + in sepsis
Budd-Chiari syndrome ± RUQ ± + in liver failure leading to varices N
Findings on CT scan suggestive of Budd-Chiari syndrome include:
Ascitic fluid examination shows:
Hemochromatosis RUQ Dull / aching + with infections and GI involvement + in cirrhotic patients may be in cardicmyopathy
  • >60% TS
  • >240 μg/L SF
  • Raised LFT
    Hyperglycemia
Ultrasound shows evidence of cirrhosis Extra intestinal findings:
  • hyperpigmentation
  • Diabetes mellitus
  • Arthralgia
  • Impotence in males
  • Cardiomyopathy
  • Atherosclerosis
  • Hypopituitarism
  • Hypothyroidism
  • Extrahepatic cancer
  • Prone to specific infections
Cirrhosis + RUQ + varices
Peritoneal causes Spontaneous bacterial peritonitis + Diffuse + in cirrhotic patients ± Hypoactive
  • Ascitic fluid PMN>250 cells/mm³
  • Culture: Positive for single organism
Ultrasound for evaluation of liver cirrhosis
Hollow Viscous Obstruction Small intestine obstruction Diffuse + ± Hyperactive then absent Leukocytosis Abdominal X ray Nausea & vomiting associated with constipation, abdominal distention
Volvulus Diffuse + Hypoactive Leukocytosis CT scan and abdominal X ray Nausea & vomiting associated with constipation, abdominal distention
Biliary colic RUQ + N Increased bilirubin and alkaline phosphatase Ultrasound Nausea & vomiting
Renal colic Flank pain N Hematuria CT scan and ultrasound Colicky abdominal pain associated with nausea & vomiting
Vascular Disorders Ischemic causes Mesenteric ischemia ± Periumbilical + Hematochezia ± Hyperactive Leukocytosis and lactic acidosis CT scan Nausea & vomiting, normal physical examination
Acute ischemic colitis ± ± Diffuse + Massive + + Hyperactive then absent Leukocytosis CT scan Nausea & vomiting
Hemorrhagic causes Ruptured abdominal aortic aneurysm Diffuse Massive + N Normal CT scan Unstable hemodynamics
Intra-abdominal or retroperitoneal hemorrhage Diffuse Massive + N Anemia CT scan History of trauma
Gynaecological Causes Tubal causes Torsion of the cyst RLQ / LLQ ± ± N Increased ESR and CRP Ultrasound Sudden onset sever pain with nausea and vomiting
Acute salpingitis + ± RLQ / LLQ ± ± N Leukocytosis Pelvic ultrasound Vaginal discharge
Cyst rupture RLQ / LLQ + ± ± N Increased ESR and CRP Ultrasound Sudden onset sever pain with nausea and vomiting
Pregnancy Ruptured ectopic pregnancy RLQ / LLQ + N Positive pregnancy test Ultrasound History of missed period and vaginal bleeding
Extra-abdominal causes Pulmonary disorders Pleural empyema + ± RUQ/Epigastric N
Cardiovascular disorders Myocardial Infarction Epigastric + in cardiogenic shock N

Differential Diagnosis of Irritable bowel syndrome on the basis of abdominal pain and diarrhea:

Diarrhea with abdominal pain/cramping may be caused by infectious diseases, celiac disease,[1] parasites,[2] food allergies[3] and lactose intolerance.[4] See the list of causes of diarrhea for other conditions which can cause diarrhea. Celiac disease in particular is most often misdiagnosed as IBS.[5] The differential diagnosis of irritable bowel syndrome based on abdominal pain and diarrhea is as follows:[6][7][8][9][10][11][12][13][14][15]

Cause Osmotic gap History Physical exam Gold standard Treatment
< 50 mOsm per kg > 50 mOsm per kg*
Watery Secretory Crohns + -
Zollinger-Ellison syndrome + -
  • Gastrin levels
  • Proton pump inhibitors
  • Octreotide
Hyperthyroidism + -
VIPoma + -
  • Elevated VIPlevels
  • Followed by imaging
Osmotic Lactose intolerance - +
Celiac disease - +
Functional Irritable bowel syndrome - - Abdominal pain or discomfort recurring at least 3 days per month in the past 3 months and associated with 2 or more of the following:
  • Onset associated with change in frequency of stool
Clinical diagnosis
  • ROME IV criteria
  • Exclusion of organic causes based on laboratory investigations and imaging

Differential diagnosis based on diarrhea

The following table outlines the major differential diagnoses based on diarrhea as the major presenting symptom:

Differential Diagnosis for Diarrhea predominant symptoms Clinical features Diagnosis
Crohn's disease
Ulcerative colitis
Microscopic colitis
Celiac disease
Neuroendocrine tumor
Hyperthyroidism
  • Serum TSH levels
Lactose intolerance
  • Avoidance trial, lactose breath test
Infectious causes
  • Abdominal discomfort, diarrhea especially in the setting of recent travel
Small bowel bacterial overgrowth
Clostridium difficile infection(Psuedomembranous colitis)

Differential diagnosis of irritable bowel syndrome on the basis of constipation:

The differential diagnosis of irritable bowel syndrome based on constipation as the predominant symptom is as follows:[16][17][18][19][20][21][22][23][24][25]

Differential Diagnosis for Constipation predominant symptoms Clinical features Diagnosis
Strictures due to diverticultis,inflammatory bowel disease, ischemia or cancer
Hypothyroidism
Medication
  • Medication history.
Neurologic disease
Pelvic floor dysfunction
  • Straining, self digitation
Colonic inertia

References

  1. Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS (2004). "Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis". Gastroenterology. 126 (7): 1721–32. PMID 15188167.
  2. Stark D, van Hal S, Marriott D, Ellis J, Harkness J. (2007). "Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis". Int J Parasitol. 31 (1): 11–20. PMID 17070814.
  3. Drisko; et al. (2006). "Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics". Journal of the American College of Nutrition. 25 (6): 514–22. PMID 17229899.
  4. Vernia P, Ricciardi MR, Frandina C, Bilotta T, Frieri G (1995). "Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet". The Italian journal of gastroenterology. 27 (3): 117–21. PMID 7548919.
  5. http://digestive.niddk.nih.gov/ddiseases/pubs/celiac/ - The United States National Institutes of Health Celiac Disease Page
  6. Guagnozzi D, Arias Á, Lucendo AJ (2016). "Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders". Aliment. Pharmacol. Ther. 43 (8): 851–862. doi:10.1111/apt.13573. PMID 26913568.
  7. Hilpüsch F, Johnsen PH, Goll R, Valle PC, Sørbye SW, Abelsen B (2017). "Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome". Scand. J. Gastroenterol. 52 (2): 173–177. doi:10.1080/00365521.2016.1242025. PMID 27796144.
  8. SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA (1964). "EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME". Gastroenterology. 47: 184–7. PMID 14201408.
  9. Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS (2004). "Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis". Gastroenterology. 126 (7): 1721–32. PMID 15188167.
  10. Irvine AJ, Chey WD, Ford AC (2017). "Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis". Am. J. Gastroenterol. 112 (1): 65–76. doi:10.1038/ajg.2016.466. PMID 27753436.
  11. van Rheenen PF, Van de Vijver E, Fidler V (2010). "Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis". BMJ. 341: c3369. PMC 2904879. PMID 20634346.
  12. Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD (2015). "Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea". Aliment. Pharmacol. Ther. 42 (1): 3–11. doi:10.1111/apt.13227. PMID 25913530.
  13. Canavan C, Card T, West J (2014). "The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study". PLoS ONE. 9 (9): e106478. doi:10.1371/journal.pone.0106478. PMC 4169512. PMID 25238408.
  14. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P (2009). "Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis". Arch. Intern. Med. 169 (7): 651–8. doi:10.1001/archinternmed.2009.22. PMID 19364994.
  15. Ford AC, Spiegel BM, Talley NJ, Moayyedi P (2009). "Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis". Clin. Gastroenterol. Hepatol. 7 (12): 1279–86. doi:10.1016/j.cgh.2009.06.031. PMID 19602448.
  16. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS (2006). "Childhood functional gastrointestinal disorders: child/adolescent". Gastroenterology. 130 (5): 1527–37. doi:10.1053/j.gastro.2005.08.063. PMID 16678566.
  17. Cash BD, Schoenfeld P, Chey WD (2002). "The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review". Am. J. Gastroenterol. 97 (11): 2812–9. doi:10.1111/j.1572-0241.2002.07027.x. PMID 12425553.
  18. Hamm LR, Sorrells SC, Harding JP, Northcutt AR, Heath AT, Kapke GF, Hunt CM, Mangel AW (1999). "Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria". Am. J. Gastroenterol. 94 (5): 1279–82. doi:10.1111/j.1572-0241.1999.01077.x. PMID 10235207.
  19. Prott G, Shim L, Hansen R, Kellow J, Malcolm A (2010). "Relationships between pelvic floor symptoms and function in irritable bowel syndrome". Neurogastroenterol. Motil. 22 (7): 764–9. doi:10.1111/j.1365-2982.2010.01503.x. PMID 20456760.
  20. Voderholzer WA, Schatke W, Mühldorfer BE, Klauser AG, Birkner B, Müller-Lissner SA (1997). "Clinical response to dietary fiber treatment of chronic constipation". Am. J. Gastroenterol. 92 (1): 95–8. PMID 8995945.
  21. Spiller R, Camilleri M, Longstreth GF (2010). "Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes?". Clin. Gastroenterol. Hepatol. 8 (2): 125–9, discussion 129–36. doi:10.1016/j.cgh.2009.12.018. PMID 20152787.
  22. Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K (2010). "Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial". Am. J. Gastroenterol. 105 (4): 890–6. doi:10.1038/ajg.2010.53. PMC 3910270. PMID 20179692.
  23. Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD (2010). "The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial". Am. J. Gastroenterol. 105 (4): 859–65. doi:10.1038/ajg.2010.55. PMC 2887227. PMID 20179696.
  24. Begtrup LM, Engsbro AL, Kjeldsen J, Larsen PV, Schaffalitzky de Muckadell O, Bytzer P, Jarbøl DE (2013). "A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome". Clin. Gastroenterol. Hepatol. 11 (8): 956–62.e1. doi:10.1016/j.cgh.2012.12.038. PMID 23357491.
  25. Mehdi Z, Sakineh E, Mohammad F, Mansour R, Alireza A (2012). "Celiac disease: Serologic prevalence in patients with irritable bowel syndrome". J Res Med Sci. 17 (9): 839–42. PMC 3697208. PMID 23826010.

Template:WH Template:WS |}